Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine

被引:89
作者
Ando, S
Kobayashi, S
Waki, H
Kon, K
Fukui, F
Tadenuma, T
Iwamoto, M
Takeda, Y
Izumiyama, N
Watanabe, K
Nakamura, H
机构
[1] Tokyo Metropolitan Inst Gerontol, Neuronal Funct Res Grp, Itabashi Ku, Tokyo 1730015, Japan
[2] Tokyo Metropolitan Inst Gerontol, Div Neurosci, Cell Recognit Res Grp, Itabashi Ku, Tokyo 1730015, Japan
[3] Tokyo Metropolitan Inst Gerontol, Div Physiol & Aging, Ageing Organ & Tissue Res Grp, Tokyo 1730015, Japan
[4] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata 94021, Japan
[5] Saitama Med Sch, Dept Anat, Moroyama, Saitama, Japan
关键词
dementia model; entorhinal cortex; botulinum toxin; learning; memory; BDNF; carnitine; synaptic plasticity;
D O I
10.1002/jnr.10443
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A rat dementia model with cognitive deficits was generated by synapse-specific lesions using botulinum neurotoxin (BoNTx) type B in the entorhinal cortex. To detect cognitive deficits, different tasks were needed depending upon the age of the model animals. Impaired learning and memory with lesions were observed in adult rats using the Hebb-Williams maze, AKON-1 maze and a continuous alternation task in T-maze. Cognitive deficits in lesioned aged rats were detected by a continuous alternation and delayed non-matching-to-sample tasks in T-maze. Adenovirus-mediated BDNF gene expression enhanced neuronal plasticity, as revealed by behavioral tests and LTP formation. Chronic administration of carnitine over time pre- and post-lesions seemed to partially ameliorate the cognitive deficits caused by the synaptic lesion. The carnitine-accelerated recovery from synaptic damage was observed by electron microscopy. These results demonstrate that the BoNTx-lesioned rat can be used as a model for dementia and that cognitive deficits can be alleviated in part by BDNF gene transfer or carnitine administration. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:519 / 527
页数:9
相关论文
共 73 条
  • [61] TETANUS AND BOTULINUM-B NEUROTOXINS BLOCK NEUROTRANSMITTER RELEASE BY PROTEOLYTIC CLEAVAGE OF SYNAPTOBREVIN
    SCHIAVO, G
    BENFENATI, F
    POULAIN, B
    ROSSETTO, O
    DELAURETO, PP
    DASGUPTA, BR
    MONTECUCCO, C
    [J]. NATURE, 1992, 359 (6398) : 832 - 835
  • [62] EFFECT OF ACETYL-L-CARNITINE ON THE DOPAMINERGIC SYSTEM IN AGING BRAIN
    SERSHEN, H
    HARSING, LG
    BANAYSCHWARTZ, M
    HASHIM, A
    RAMACCI, MT
    LAJTHA, A
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 1991, 30 (03) : 555 - 559
  • [63] Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease
    Shimohama, S
    Kamiya, S
    Taniguchi, T
    Akagawa, K
    Kimura, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (02) : 239 - 242
  • [64] ACETYL-L-CARNITINE ATTENUATES NEURONAL DAMAGE IN GERBILS WITH TRANSIENT FOREBRAIN ISCHEMIA ONLY WHEN GIVEN BEFORE THE INSULT
    SHUAIB, A
    WAQAAR, T
    WISHART, T
    KANTHAN, R
    HOWLETT, W
    [J]. NEUROCHEMICAL RESEARCH, 1995, 20 (09) : 1021 - 1025
  • [65] Su Y, 1998, J NEUROSCI RES, V53, P177, DOI 10.1002/(SICI)1097-4547(19980715)53:2<177::AID-JNR6>3.0.CO
  • [66] 2-4
  • [67] Restoration of decreased N-methyl-D-asparate receptor activity by brain-derived neurotrophic factor in the cultured hippocampal neurons:: Involvement of cAMP
    Sun, JH
    Yan, XQ
    Xiao, H
    Zhou, JW
    Chen, YZ
    Wang, CA
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 394 (02) : 209 - 215
  • [68] ACETYL-1-CARNITINE TREATMENT INCREASES NERVE GROWTH-FACTOR LEVELS AND CHOLINE-ACETYLTRANSFERASE ACTIVITY IN THE CENTRAL-NERVOUS-SYSTEM OF AGED RATS
    TAGLIALATELA, G
    NAVARRA, D
    CRUCIANI, R
    RAMACCI, MT
    ALEMA, GS
    ANGELUCCI, L
    [J]. EXPERIMENTAL GERONTOLOGY, 1994, 29 (01) : 55 - 66
  • [69] PHYSICAL BASIS OF COGNITIVE ALTERATIONS IN ALZHEIMERS-DISEASE - SYNAPSE LOSS IS THE MAJOR CORRELATE OF COGNITIVE IMPAIRMENT
    TERRY, RD
    MASLIAH, E
    SALMON, DP
    BUTTERS, N
    DETERESA, R
    HILL, R
    HANSEN, LA
    KATZMAN, R
    [J]. ANNALS OF NEUROLOGY, 1991, 30 (04) : 572 - 580
  • [70] A 1-year controlled trial of acetyl-L-carnitine in early-onset AD
    Thal, LJ
    Calvani, M
    Amato, A
    Carta, A
    [J]. NEUROLOGY, 2000, 55 (06) : 805 - 810